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ABSTRACT
We are frequently faced with a large collection of antibodies, and want to select those with
highest affinity for their cognate antigen. When developing a first-line therapeutic for a novel
pathogen, for instance, we might look for such antibodies in patients that have recovered. There
exist effective experimental methods of accomplishing this, such as cell sorting and baiting; how-
ever they are time consuming and expensive. Next generation sequencing of B cell receptor (BCR)
repertoires offers an additional source of sequences that could be tapped if we had a reliable
method of selecting those coding for the best antibodies. In this paper we introduce a method that
uses evolutionary information from the family of related sequences that share a naive ancestor to
predict the affinity of each resulting antibody for its antigen. When combined with information on
the identity of the antigen, this method should provide a source of effective new antibodies. We
also introduce a method for a related task: given an antibody of interest and its inferred ancestral
lineage, which branches in the tree are likely to harbor key affinity-increasing mutations? These
methods are implemented as part of continuing development of the partis BCR inference package,
available at https://github.com/psathyrella/partis.
Comments. Please post comments or questions on this paper as new issues at https://git.io/
Jvxkn.
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2INTRODUCTION
Antibodies are the foundation of both vaccine-induced immunity and many important ther-
apeutics. They stem from B cells through the processes of VDJ rearrangement and somatic hy-
permutation (SHM), which yield a vast repertoire of B cell receptors (BCRs) within each person.
Each clonal family begins from a single naive B cell that has encountered its cognate antigen,
which then reproduces in a germinal center (GC), diversifying and evolving as SHM drives affin-
ity maturation. We can probe the BCR repertoire via next generation sequencing (NGS), and with
computational methods divide it into groups of clonally-related sequences [1] stemming from the
same rearrangement event (clonal families).
Of the many sequences in the BCR repertoire, we are generally interested in those that code
for the highest affinity antibodies. There exist several effective experimental methods of finding
high affinity B cells. Both cell sorting and antigen baiting have been used to find a variety of
important antibodies [2–4]. These approaches have several challenges. For instance, constructing
a stable baiting antigen for certain conformational epitopes can be challenging. However their
main limitation is that they require large investments of time and resources.
Deep sequencing of the BCR repertoire yields tens of thousands to millions of sequences from
this same pool, some of which undoubtedly correspond to high affinity antibodies. And in many
cases, this NGS data already exists, since it is frequently collected as a matter of course when
studying, for instance, antibodies isolated using the cell sorting approach. If we had some way of
identifying a handful of these sequences that are likely to correspond to high affinity antibodies,
then they could be synthesized and tested for their binding properties. This could yield a rich
source of novel antibodies.
In most practical cases we would like to choose only antibodies that are effective against a
particular pathogen or epitope. Because the evolutionary signatures in sequence data can tell
us much more about affinity than they can about specificity, we separate this task into two parts:
finding antibodies or families with the desired specificity, and finding antibodies with high affinity
regardless of specificity. While de novo epitope prediction from sequence data alone is a rapidly
developing field, the challenges are still such that specificity determination is best accomplished
3with non-sequence-based information, such as cell sorting or information about vaccine challenge.
Because our expertise is solely in analyzing sequence data, the methods in this paper thus deal only
with affinity prediction. However, to give an idea of what is possible, we also review techniques
that have been used to enrich for particular specificities (see Discussion).
In our experience, there are two common use cases for methods of choosing antibodies from
NGS data, depending on what prior information is available. If we have a previously-isolated
antibody of interest, then specificity has already been determined and we want to choose only
among the sequences in that antibody’s family. In the absence of such an antibody, we are instead
choosing from among many different families in the repertoire, and our affinity prediction meth-
ods must be paired with some method of enriching for families with the desired specificity. While
the second case is more difficult, because both affinity and specificity vary between families, it
also holds the promise of much greater rewards, since novel antibodies from previously unknown
families could bind with much higher affinity, or to new epitopes.
In this paper we first test, on both simulated and real data samples, a variety of methods to
choose individual high-affinity sequences both from within single families, and from among all
families of a given specificity in the repertoire. We find that an observed sequence’s similarity
to its family’s amino acid consensus sequence (measured by hamming distance, and abbreviated
aa-cdist) is a highly effective predictor of affinity in both of these cases. Because the other, more
poorly performing metrics provide independent information not in aa-cdist, we also combined
them using several machine learning approaches. We were not, however, successful in training
such a method that substantially outperformed aa-cdist, which we believe is likely due to several
unique features of the combined tree and sequence spaces.
We next introduce an entirely new metric to predict the change in affinity along each branch
of a family’s inferred phylogenetic tree (abbreviated ∆-affinity). This new metric, called local
branching ratio (lbr), draws on ideas from [5] and [6]. It is designed for situations where we have
an antibody of interest, and want to know which branches along its inferred lineage are likely to
harbor the most important mutations.
4Since we focus on B cells we desire to predict affinity, which in our simulations we define as
the inverse of the dissociation constant in a biochemically-motivated model (see Methods). How-
ever the metrics we test are more directly measuring evolutionary fitness (the expected number of
offspring), and are thus also of much wider applicability. For instance, while writing this paper
we discovered that some of the authors of [5] had concurrently found that aa-cdist is predictive of
fitness in the context of viral evolution, and also derived a mathematical proof that aa-cdist is in
some circumstances the optimal metric [7]. We would also expect lbr to predict fitness-increasing
mutations in an inferred viral lineage just as effectively as it predicts affinity increases for antibod-
ies.
These metrics are essentially evolutionary in nature, and thus require at least a handful of se-
quences from each clonal family. All of these metrics can be calculated with simple options in
the freely available partis software package https://github.com/psathyrella/partis, which
also performs BCR annotation, simulation, clonal family clustering, and per-sample germline in-
ference [1, 8, 9]. However, we note that aa-cdist is simple enough that for users who have already
grouped their sequences into clonal families, a simple sequence alignment GUI may suffice.
RESULTS
Affinity and fitness. The metrics that we use to predict affinity and ∆-affinity for each sequence
begin by considering that sequence in the context of its clonal family of related sequences. Whether
this context is a phylogenetic tree or a sequence alignment, it provides information about the
evolutionary history that led to the sequence’s development. The metrics use this information
to find the sequences stemming from cells that were fittest, in the evolutionary sense, during the
GC reaction. Because a key purpose of the GC reaction is to apply selective pressure in order to
direct evolution toward antibodies that bind to pathogens with high affinity, fitness is generally
correlated with affinity. It is important to note, however, that this fitness also depends on other
factors, such as the ability to recruit T cell help. We thus generally refer to “predicting affinity”
in this paper, but it should be understood that the metrics are more directly connected to GC
reaction fitness, and the extent to which this fitness correlates to affinity must be judged on a case
5by case basis, particularly in real data. In simulation, we define specific mathematical connections
between each sequence’s affinity and its expected number of offspring. The two real data samples
in this paper, in contrast, measure neutralization concentration rather than affinity, and while these
quantities are generally expected to correlate, we cannot say to what extent in any specific instance.
Metrics. We measured the ability of a variety of metrics to predict affinity and ∆-affinity, all of
which are summarized in Table 1. Each is also described in the following paragraphs.
As mentioned above, each observed sequence’s hamming distance to its family’s amino acid
consensus (abbreviated aa-cdist) is the best predictor of affinity (where smaller distance is bet-
ter). While this metric has been used in an ad hoc way [10], to our knowledge the only attempt
to measure its performance was [11], which tested on only a single, small family in the supple-
mental information. In many cases the calculated consensus sequence itself is not observed, and
it is possible that in such cases this unobserved consensus would be a better predictor than the
nearest observed sequence, but we have not evaluated this (see Discussion). When calculating
the consensus, ties are treated as ambiguous positions, which are then ignored in the hamming
distance.
Local branching index (abbreviated lbi) uses the family’s phylogenetic tree to measure the
“branchiness” in the local area around each node [5]. This branchiness is calculated by integrat-
ing the total branch length surrounding the node with a decaying exponential weighting factor
(S1 Figure). While lbi performs worse than aa-cdist in almost all regions of parameter space, it is
nevertheless important because it contains some independent information, provides an obvious
path to improving aa-cdist, and serves as the basis for lbr. Our implementation of lbi includes
several modifications to the original formulation. We perform an independent optimization of the
τ locality parameter, although we arrive at a comparable final value. We also introduce a nor-
malization scheme, which although amounting only to a switch to human-interpretable units, is
important because without it lbi calculated in different papers with different τ values cannot be
compared.
6We also introduce a new version of local branching index that incorporates only nonsynony-
mous mutations (abbreviated aa-lbi), which significantly outperforms the original nucleotide ver-
sion in all regions of parameter space. It in fact outperforms aa-cdist in some regions; however
(like lbi) its poor performance with low selection strength and when choosing among all families
recommend against its use as a standalone metric.
Because affinity maturation via somatic hypermutation should be, in the long run, an affinity-
increasing process, many papers have used the number of somatic mutations as a proxy for affinity
(abbreviated n-shm, and distinguished from our abbreviation SHM for the process). Unfortu-
nately in practice this metric performs very poorly because it chooses leaves, which harbor many
novel mutations. Novel mutations are in general overwhelmingly deleterious, and in leaves have
not yet been evaluated by significant selective pressure. The underlying idea that affinity increases
with distance from root is valid; however it is necessary to go some way back toward root from
the leaves (indeed this is what aa-cdist accomplishes).
In addition to aa-cdist, we also show results for its nucleotide analog nuc-cdist. This is useful
mainly as a way to understand the importance of information from the amino acid translation
table, and thus differences between aa-cdist and lbi.
An additional metric that we do not evaluate is the multiplicity of each unique sequence. It can
be experimentally challenging to disentangle underlying cell numbers from other factors such as
primer bias and varying expression levels [12–14]. Thus while higher multiplicity is sometimes
used as a standalone metric to predict higher fitness [10], we do not evaluate it here because many
data sets that we encounter do not include the measures necessary for an accurate estimation. For
samples that are known to have reliable multiplicity information, however, this can be passed to
partis (see https://git.io/JJCGe), and our implementations of lbi, aa-lbi, and aa-cdist include
extensions such that it will be properly accounted for in the calculations (see Methods).
To predict affinity-increasing mutations (∆-affinity) we mainly focus on the local branching
ratio lbr. This novel metric uses the same branch length integrals as lbi, but instead of summing
in all directions, it compares the branchiness among the node’s offspring to that of its parents
and siblings (S1 Figure). This ratio of branchiness below vs above the node thus quantifies the
7possibility that an affinity-increasing mutation occurred along the branch immediately above the
node, since such a mutation would increase fitness among the node’s offspring.
In order to provide some baseline for the effectiveness of lbr, we also evaluate the change in
lbi from the parent node (abbreviated ∆-lbi) as a predictor of ∆-affinity. While this functions
adequately, it is always significantly worse than lbr.
As for lbi, we also introduce an amino acid version of lbr (abbreviated aa-lbr); however it does
not perform better than the standard version.
Evaluation framework. The first step toward confidence in any method is measuring its perfor-
mance in all corners of its parameter space. For the metrics in this paper, that space is constructed
from sequences and trees and is vast, complicated, and high-dimensional. In order to measure
performance, we began with a previously-described simulation framework [15], extending it to
allow a more comprehensive variation of parameters, and rewriting to optimize for speed. We
then performed scans across all reasonably plausible values of parameters that could affect perfor-
mance.
The simulation begins by constructing a naive sequence via VDJ rearrangement. It then chooses
a number of “target” sequences at some distance from the naive, each of which represents a poten-
tial optimal antibody. Repeated rounds of SHM then apply selective pressure to direct the naive
sequence’s offspring toward these targets.
We measure performance using a metric called ”quantile to perfect” that we believe emphasizes
the practical use case for these metrics: choosing a handful of sequences from deep sequencing
data in order to invest substantial resources into synthesis and binding evaluation. While these
metrics predict affinity, and are thus correlated with it, quantifying overall correlation with some-
thing like the Pearson coefficient would not measure effectiveness for our use case. This is because
we only care about the very small fraction of sequences at the highest affinity values, whereas
measures of overall correlation count all sequences equally and are thus dominated by low- and
medium-affinity sequences. We instead imagine that we have chosen the top few sequences ac-
cording to the predictive metric, and then ask whether they are also among the top few in affinity.
We quantify this by taking the average of their affinity quantiles. We then compare this mean
8quantile to that of a hypothetical perfect method that simply ranks sequences by their true affinity.
The amount by which the mean affinity quantile of sequences chosen by the actual metric devi-
ates from that of the perfect metric, further averaged over quantiles from 75 to 100 (i.e. choosing
between 25% and 0% of sequences), forms the basis of our performance evaluation.
We supplement these comprehensive simulation scans with validation results on two small real
data samples.
Table 1. Metrics used in this paper to predict affinity (top) and ∆-affinity (bottom). Those
marked with a * perform much better than the others, and are recommended for all practical
use. The sign of the metric’s correlation with the predicted quantity is indicated by “± corr.”.
affinity metrics shorthand ± corr. description
AA consensus distance * aa-cdist - hamming distance to the clonal family’s amino acid consensus sequence
local branching index lbi + total branch length in the local area of the (nucleotide) tree [5]
AA local branching index aa-lbi + lbi calculated on a tree reflecting only nonsynonymous mutations
somatic hypermutations n-shm + number of nucleotide somatic hypermutations
nucleotide consensus distance nuc-cdist - nucleotide version of aa-cdist
∆-affinity metrics shorthand ± corr. description
local branching ratio * lbr + ratio of total branch length in the (nucleotide) tree below the node to above the node
change in lbi ∆-lbi + change in local branching index compared to the parent node
AA local branching ratio aa-lbr + lbr calculated on a tree reflecting only nonsynonymous mutations
Simulation results. We first show simulation performance for a single parameter scan for both
affinity and ∆-affinity prediction (Fig 1 and Fig 2). This scan varies observation time (in units of
N generations) from 50 to 3000 while holding other variables constant. This corresponds roughly
to varying the mean frequency of somatic nucleotide mutations among observed sequences from
2% to 25%.
We then show analogous scans for a variety of other parameters when choosing within fami-
lies (S2 Figure; the corresponding among-families plots may be found at https://zenodo.org/
record/3929565). These scans correspond to varying the most important simulation parame-
ters: longitudinal sampling, carrying capacity, number of sampled sequences, sequence-to-affinity
mapping, and selection strength. Generalizing across these scans, we find that aa-cdist performs
consistently better than most other metrics, typically at 5-10% from perfect. aa-cdist’s performance
is largely recapitulated, and sometimes slightly exceeded, by aa-lbi. aa-lbi frequently has a slight
9advantage when choosing within a family and at very early observation times, while aa-cdist is
often better choosing among families and at long times. However their behavior diverges as we
vary selection strength (S2 Figure bottom right), with aa-lbi doing slightly better for high selection
strength, but dramatically worse near neutral evolution. Also of note, nuc-cdist performs simi-
larly to, but worse than, lbi in many of the scans. This is consistent with the hypothesis that under
high selection strength the local branching calculation does a better job of quantifying branchi-
ness/evolutionary density than does consensus distance, but that this advantage is overwhelmed
by the large benefit to including amino acid information in aa-cdist. Under low selection strength,
on the other hand, there is little for the local branching calculation to measure. Meanwhile n-shm
performs much worse than the other metrics in almost all situations. We also show performance
for a variety of different models of cell export from the GC (S3 Figure), as well as the effect of
varying the number of “target sequences” (the simulation’s representation of hypothetical ideal
antibodies, S4 Figure).
In order to provide a more stringent test of performance when choosing among all families, we
also show results on samples where (unlike those described above) parameters vary between the
families in each sample (S5 Figure). We first observe that, as in Fig 1, all methods perform better
when choosing within families (left column) than among them (right column). To evaluate the
effects of adding between-family parameter variance on choosing among families (right column),
we focus on whether the vertical spread of values left of the dashed line encompasses the values
to its right. In other words, the points left of the dashed line tell us the effect of changing the mean
values of the parameters (but with no between-families variance), while those right of it tell us
the effect of adding variance between families. The biggest effect of adding this variance is that
n-shm performs much worse when observation time (i.e. % SHM) varies between families (right
plot in third row), however it also appears that aa-cdist degrades by about 5% when selection
strength varies between families (right plot in second row). These surprisingly moderate effects
are likely because families vary widely in their final characteristics even when they start with
the same parameter values, since almost all important characteristics are determined by the very
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small (typically 3 − 5), and thus highly stochastic, number of beneficial mutations that occurs in
each family.
In the ∆-affinity prediction (Fig 2) lbr performs much better than ∆-lbi, on average identifying
a branch that is 0.1 − 0.2 steps in the tree from the branch that actually has an affinity-increasing
mutation. This can be thought of as choosing the correct branch eight or nine out of ten times, and
being one branch away the other one or two times. aa-lbr, on the other hand, performs similarly
to lbr, i.e. in contrast to (absolute) affinity prediction, the addition of amino acid information does
not improve performance. The ∆-affinity performance plots for the remaining parameter scans
are at https://zenodo.org/record/3929565; they show lbr typically between 0.1 and 0.5 steps
from perfect, and consistently much better than ∆-lbi (but similar to aa-lbr).
Many other variations of these parameter scans, and plots comparing multiple slices for each
metric, can be found at https://zenodo.org/record/3929565.
Data results. Validation on real sequence data serves a different, complementary purpose to val-
idation on simulation. Real data validation is more stringent, and thus more useful, in the sense
that by definition it perfectly recapitulates the properties of real data. But on the other hand
real data is less stringent, and thus less useful, because it is more difficult to produce and thus
is only ever available for a very restricted set of parameter values. For instance looking at one
real data sample might only explore large, high-mutation trees with strong selection, but ignore
performance at other parameter values. This means that designing any method using real data
validation alone is extremely risky, since it only provides information about how the method per-
forms for the particular combination of parameters in those data sets. In the present case, because
affinity is so expensive to measure, real data has a further problem: while there are many papers
with both NGS data and affinity information (e.g. [2, 16–31]), to our knowledge very few of them
both measure affinity for more than a handful of sequences per clonal family and have made that
data public. This is, nevertheless, certainly better than nothing, and can provide confidence that
nothing has gone egregiously wrong in the simulation studies.
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Fig 1. Simulation performance for affinity prediction vs. observation time
when choosing sequences within each family (left) and among all families of
a given specificity in the repertoire (right) for the metrics in Table 1. The y-
axis describes how close each metric comes to achieving the best possible per-
formance. For example a value of 5 “quantiles to perfect” for aa-cdist would
mean that choosing the top 7% of sequences using aa-cdist would give you se-
quences that, on average, are in roughly the top 12% of affinity. An observa-
tion time of 50 (3000) generations corresponds to a nucleotide SHM frequency
of roughly 2% (25%). The longer simulation times should be thought of as a
series of GC reaction/reentry cycles, as would for instance be seen during anti-
HIV bNAb development over several years. Each point shows the mean ± stan-
dard error of 30 samples, where each sample consists of 1500 sequences from
10 families. Similar plots across ranges of other simulation parameters can be
found in S2 Figure, S5 Figure, S3 Figure, S4 Figure, and at https://zenodo.org/
record/3929565.
Here we have chosen data from two well-known papers on anti-HIV antibodies [32, 33]. There
are several aspects of HIV that, a priori, we expected would make it a very challenging environ-
ment for these metrics. First, these papers both measure IC50 neutralization concentrations rather
than affinity. To handle this we simply use 1/IC50 in place of affinity, and hope that neutralization
and affinity are correlated enough for the metrics to work. Second, HIV’s vast diversity both glob-
ally and within each subject means that the viruses that applied selective pressure during each
antibody’s development were in all likelihood quite different from the viruses against which the
antibodies’ neutralization strengths were tested. These papers also report the geometric mean IC50
over many viruses from the three main global HIV clades, and for the sake of simplicity we use
12
Fig 2. Simulation performance for ∆-affinity prediction vs. observation time
for the metrics in Table 1. The y-axis describes how close each metric comes to
achieving the best possible performance. Here we are predicting the location of
affinity-increasing mutations in a lineage of inferred ancestral sequences, and for
example a value of 0.5 “N ancestors to perfect” for lbr would mean that if we
choose the best inferred ancestral sequence using lbr that we would, on average,
be 0.5 branches away from a branch containing an actual affinity-increasing muta-
tion. See Fig 1 caption for details. Similar plots across ranges of other simulation
parameters can be found at https://zenodo.org/record/3929565.
these overall values for validation. As for almost all current work, these papers also use unpaired
sequencing, which not only ignores any signal from light chain evolution, but also typically means
measuring IC50 values for chimeric antibodies with non-native light chain sequences. Finally, we
note that these are the only real data samples on which we have run our methods – it would
of course have been uninformative to run on many different samples before deciding which to
include in this paper.
With the final reminder that these are extremely small sample sizes, we find that on real data
both aa-cdist (Fig 3) and lbi (S6 Figure) perform roughly in line with expectations from simulation.
We find that aa-cdist is generally between 0 and 20 quantiles from perfect, while lbi ranges from
10 to 30.
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Fig 3. Performance on real data for aa-cdist from [32] (top) and [33] (bottom).
The scatter plots (left) show the raw correlation between aa-cdist and measured
“affinity” (here actually 1/IC50), while the quantile plots (right) show the relative
affinity ranking for sequences chosen using aa-cdist (blue) compared to perfect
(green) and random chance (red). For instance, an x value of 85 on the top right
plot corresponds to 75 on the y axis, meaning that if we chose the top 15% of
sequences using aa-cdist that these sequences would on average rank in the top
25% by affinity (thin red lines). Another way of viewing this is that, at x of 85, the
blue line is about 20% below the green line, meaning performance is 20% worse
than perfect; this interpretation corresponds to the values shown in the top row
of Fig 2. We also show the equivalent plots for lbi (S6 Figure).
DISCUSSION
We have demonstrated effective, practical methods for two tasks common to the analysis of B
cell receptor deep sequencing data. First, we find that a sequence’s similarity to its clonal fam-
ily’s amino acid consensus (aa-cdist) is an excellent predictor of that sequence’s affinity, and is
a highly effective way to choose a handful of sequences for synthesis and testing. Second, we
find that a new metric that we construct called local branching ratio (lbr) is similarly effective
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for the related task of predicting which branches in a single lineage are likely to harbor affinity-
increasing mutations (i.e. predicting ∆-affinity). These metrics are both implemented in the ex-
isting partis annotation and clonal family inference package, available at https://github.com/
psathyrella/partis. By testing performance on simulation generated with a wide variety of pa-
rameters, we showed that choosing the best few sequences according to these metrics will likely
result in antibodies that are also among the highest affinity. We further find that the number of so-
matic hypermutations (n-shm), while a frequently-used heuristic affinity predictor [10], performs
very poorly. We also showed performance on two very small real data samples, which provide
a confidence-boosting cross check. We emphasize that in these methods we make no attempt at
specificity prediction, since this is better achieved through non-sequence-based methods such as
clinical information (e.g. use of vaccine challenge). Thus in cases where no previously-isolated
antibody is available to restrict consideration to a single family, while aa-cdist is effective at choos-
ing the highest affinity antibodies from among many families, it is necessary to pair it with a
non-sequence-based method of enriching for families with the desired specificity. Many examples
of such methods are described below (see Previous work).
There are many avenues for future improvement to these methods. We currently use the plain
consensus, which by considering each site independently ignores information about how sequences
evolved together at different sites. By taking a single family-wide consensus, it also does a rela-
tively poor job of handling families with several widely-separated branches. While its perfor-
mance does not drop significantly in such cases (this is tested by the variety of target sequence
configurations in S4 Figure), there is likely room for improvement. When presented with widely-
separated branches, the consensus calculation will in many cases simply ignore all but the largest
branch. This is not ideal, since when evolving toward separate targets, the less-numerous branches
might hold a significant number of effective antibodies. We could address this by adding locality
to the consensus calculation, perhaps by dividing the tree into sublineages and then calculating
the consensus for each sublineage [34].
We instead introduced aa-lbi as an initial effort to combine aa-cdist and lbi, since it provided
a simpler path to implementation. The addition of amino acid information indeed dramatically
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improves performance: aa-lbi does much better than lbi almost everywhere, in fact largely reca-
pitulating the performance of aa-cdist. It does not, however, perform well in near-neutral evo-
lutionary scenarios, which are likely a common feature of real data [35]. Thus although aa-lbi is
promising, we do not recommend it for general use at this time.
Another disadvantage of aa-lbi is that the necessary phylogenetic tree and ancestral sequence
inference add additional uncertainty and computation time. The results presented here bench-
mark aa-lbi on the true tree and ancestral sequences, rather than the noisy reconstruction one
would obtain given real data. Although (nucleotide) lbi performs to expectation on small real data
samples (S6 Figure), and we show that lbi appears largely insensitive to poor phylogenetic infer-
ence (S8 Figure), we have not quantified the effect of this inference uncertainty on performance,
and in some cases it could be significant. For aa-cdist, on the other hand, while the consensus
of a small number of sampled sequences is not a perfect predictor of the full-family consensus
(S7 Figure), there is no inference uncertainty inherent to the (very simple) consensus calculation.
Towards a different future direction, we acknowledge that the assumption that all sites are
equivalent is particularly inaccurate for BCR sequences: not only are the complementarity deter-
mining regions (CDRs) more important for binding than framework regions (FWKs), but activation-
induced deaminase (AID) activity results in strongly context-dependent mutation patterns. This
information could be incorporated into aa-cdistwhen calculating the hamming distance by assign-
ing different weights to different regions, perhaps using [36] or [37]. For instance, hypothetically,
perhaps a one amino acid difference in the CDR should count for twice (or half) as much as a differ-
ence in FWK. Similarly, perhaps mutations at highly mutable positions should count less toward
the distance than those at less mutable positions. This approach could be further improved by
incorporating structural and functional information, for instance using deep mutational scanning
data such as [38] to develop models of binding change upon mutation.
Another limitation of these metrics is that they do not incorporate information from insertion
or deletion mutations (SHM indels). Because SHM indels can have a large impact on function in
the (relatively rare) cases where they occur, this is a significant limitation. Since indels are not
generally treated as informative characters by tree inference programs, this limits the potential
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utility of adding SHM indel information to the tree-based metrics in the near future. It would
probably be possible, however, to design a new consensus calculation that incorporates indels
into aa-cdist; however we have not experimented with this approach.
While aa-cdist performs well on its own, there is clearly significant independent information
in the remaining metrics. We thus invested a large effort in developing a machine learning ap-
proach incorporating many different tree and sequence variables (Table 3). We found the best
performance with a decision tree regression (abbreviated dtr), but were unable to significantly and
consistently improve on the performance of aa-cdist alone. We believe this failure stems from two
factors. First, it is possible that there isn’t that much additional information in the other variables:
aa-cdist is in many regions already quite close to perfect. Second, because the relative perfor-
mance of different metrics varies dramatically between different parts of parameter space, the dtr
has to make a very accurate determination of its location in this space before deciding how to
use the input variables. In making this determination, however, it is limited to inferred variables,
which provide only a tenuous link to true parameter space. To take one example, the relative use-
fulness of lbi and n-shm completely reverses between low and high selection strength (blue and
orange in bottom right of S2 Figure). While the dtr input variable Fay/Wu H does predict selection
strength [35], it is far too noisy to give the dtr an accurate idea where along the x axis it is for a
given family (results not shown). We thus find that the dtr generally recapitulates the performance
of the best single metric at each point in parameter space, but is rarely much better, and sometimes
a bit worse. Since the best single metric is usually aa-cdist, and aa-cdist is both vastly simpler to
calculate and interpret and is not subject to even the possibility of overtraining, this means that
aa-cdist is a better choice overall.
Finally, while it is clear that the observed sequence that falls closest to the family consensus
is likely of high affinity, we have not tested whether the actual consensus sequence (when it is
not observed) would be even better. The selection of such an unobserved consensus sequence for
synthesis would be risky, since unlike observed sequences, there would be little direct evidence
showing that it produces a stable, functional antibody. However, it is possible that this would be a
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good strategy in cases where the overriding goal is finding the antibody with the highest possible
affinity, and where synthesizing one extra sequence is not a large burden.
Shifting now to predicting affinity-increasing mutations, aa-lbr’s performance is largely identi-
cal to that of lbr, showing that in contrast to predicting absolute affinity, the incorporation of amino
acid information does not improve performance. We speculate that this could be because the high
resolution inherent to the numerator/denominator distinction that allows use of a very large τ
(see Methods) means that lbr already sees far enough up and down the tree to average out syn-
onymous mutations. Another avenue for improvement could be drawing more explicitly on the
analogy to absolute affinity prediction, such as using the change (from parent node) in hamming
distance to a local amino acid consensus sequence.
An additional concern with lbr is that because it is sensitive to the detailed long range ancestral
lineage structure, it requires more accurate phylogenetic inference than lbi (S8 Figure). While lbi
performs well even with the very heuristic (but also very fast) trees that partis makes by default,
lbr would benefit from the more sophisticated inference provided by external packages such as
linearham [39] or RAxML [40]. Because they also provide ancestral sequence inference, these pro-
grams will in any case usually be required for lbr, since unless internal branches are short enough
to contain only a few mutations, a prediction of which branches contain important mutations is
not very meaningful.
Previous work. Because the metrics we have presented do not provide information on speci-
ficity, we first review prior work on ways to enrich for antibodies that are specific to a particular
pathogen or epitope. These use information from sources beyond the NGS data, and will pro-
vide a key component of most practical workflows involving our methods. As described above,
cell sorting and baiting provide a very direct way to identify antigen-specific antibodies, and thus
when combined with partis seed sequence clustering, also antigen-specific families in the NGS
data (see [41] for an example of this workflow). Yeast display can be used for high-throughput
specificity and affinity screening of natively paired heavy and light chains [42]. A very recent
paper uses a microfluidics-based approach to experimentally evaluate antibody specificity in high
throughput [43] (of particular relevance to our results, they find no correlation between n-shm and
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measured affinity). Another recent paper clusters sequences into specificity groups using amino
acid hamming distance on a subset of CDR residues deemed likely to contribute to binding [44].
These paratope residues are chosen using a deep learning approach trained on a large database
of existing structural data [45]. This is a particularly exciting complement to our affinity predic-
tion methods, since given an antibody of interest it would allow consideration not just of that
antibody’s family, but also of unrelated families with similar paratopes (and thus specificities).
A less-direct way to enrich for a particular specificity is to apply a large immune stimulus,
such as vaccination, and then limit the analysis to plasma cells from families that expand around
7 days after vaccination [46–52]. In model organisms, it is also possible to cut out tissues where
antigen-specific B cells are likely to concentrate (such as lymph nodes or Peyer’s patches). With
longitudinal sampling, a family’s persistence over time can be a strong indicator of specificity in
the presence of either chronic infection [53] or the application of multiple vaccinations [49]. With
several subjects that have been exposed to the same antigen, we can select shared lineages either
using simple sequence similarity [46–48,54] or a Bayesian mixture model incorporating also clonal
abundance [55]. With an outside source of antigen-specific sequences (e.g. from cell sorting or
public databases), we can choose sequences that are similar [50].
Specificity prediction without any of these extra information sources, i.e. from sequence data
alone, is much more difficult. It would involve de novo structure and binding prediction, which
are not currently practical, although much recent work focuses on these problems [56–60].
Many papers have focused on finding families that have been subject to strong selection, which
when applied to the BCR repertoire is then assumed to correlate to families with higher affinity.
Probably the most common approach to picking highly selected families has been to measure the
ratio of nonsynonymous to synonymous mutations. Observed nucleotide mutations are separated
into synonymous (S) and nonsynonymous (NS), the ratio NS/S is calculated, and values much
larger (smaller) than one indicate positive (negative) selection. A number of corrections [61–64]
and optimizations [65] have also been developed to reduce its dependence on the baseline muta-
tion model.
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In perhaps the earliest B cell specific effort to pick families [66], the authors calculate a fairly
comprehensive variety of simple tree shape metrics on a handful of small trees (e.g. number of
nodes, root-tip distance, outgoing degree, trunk length). While some correlations were noted, it
was largely a descriptive exercise without strong quantitative conclusions. Work several years
later [67] found correlations between some of the same metrics and GC reaction parameters in a
mathematical model. However, a later paper [63] noted that neither [66] nor [67] tested under
realistic conditions: both assumed 100% sampling depth, i.e. included every cell from the GC re-
action history in the final tree. After accounting for realistic sampling, this later paper found that
the simple tree metrics lost their predictive power. They then devised a new metric combining a
small amount of tree information with NS/S by ignoring terminal mutations (which as described
above are much less likely to lead to high affinity antibodies). This is analogous to a combination
of lbi, which uses tree structure to measure selection, with aa-cdist, which reduces the influence of
tip mutations. A more recent paper [35] found that NS/S is higher in CDR than FWK regions, and
calculated the likelihood-based fitness from [5] for several trees, but found no significant relation-
ships between changes in this fitness and NS/S or CDR vs FWK.
A more complex statistic known as Fay/Wu H [68] has also been used in the context of BCR
repertoires. It quantifies any excess at high values of the site frequency spectrum, and can be
thought of as measuring the amount of shared mutation in the family, or equivalently the preva-
lence of selective sweeps. It was used in [35] to determine that families that expand rapidly in
response to vaccination are generally positively selected. We independently verified that it indeed
identifies highly-selected families (results not shown), and thus included it in the dtr.
A metric called the log offspring number ratio, which provided a starting point for lbr, was
introduced in [6]. This metric looks in the tree for pairs of sibling branches where one branch has a
mutation and the other does not. It is then calculated as the log of the ratio between the number of
offspring in the mutated vs non-mutated branches. The distribution of this value is then calculated
separately for NS and S mutations, and a rightward (leftward) shift in the NS distribution indicates
positive (negative) selection. It unfortunately is rendered less useful by several issues. First, it
counts offspring all the way down the tree, so that ancestors get credit for fitness improvements
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in all of their offspring, so it cannot be used to find the location of important mutations. It also
ignores sibling pairs in which either both edges have mutations, or either branch has multiple
mutations, which together can amount to throwing out a large fraction of the tree. Finally, it can
only detect in-progress (i.e. not-yet-fixed) incremental selection, and the NS and S mutation rates
must be of the same order of magnitude.
The remainder of previous work has focused on choosing single sequences from within a fam-
ily, and separates into experimental and theoretical studies. Experimental papers typically first
choose a family based on the methods above for specificity to the pathogen of interest, then ex-
clude sequences with “bad” features (e.g. highly hydrophobic, or with free cysteines or atypical
indels), and then rank the remaining sequences by measures such as n-shm, V gene usage, and
CDR3 length. On the theoretical side, lbi has undoubtedly enjoyed the most practical use. Intro-
duced in [5], it was originally a quick heuristic replacement for a more complex likelihood-based
metric. Its ability to predict fitness in real influenza data has been shown in [69], and it features
prominently on the nextstrain [70] web site https://nextstrain.org/flu/seasonal/h3n2/ha/
2y?c=lbi.
In the only work we’re aware of that evaluated aa-cdist, the authors adapted an approach from
structural studies called maximum entropy [11]. This models the multiple sequence alignment of a
family as a multivariate gaussian, and then takes probability (i.e. nearness to a gaussian’s peak) as
a correlate of affinity. This maximum entropy metric performs well in their tests, however its gen-
erality is unknown, since it was trained and tested using only one relatively small real data sample.
Although they avoid statistical overtraining by training and testing on disjoint parts of the sample,
a single sample can only tell us about performance at the one point in parameter space at which it
resides. Furthermore, since training consists of optimizing to that particular sample, other regions
of parameter space are by construction very likely to have worse performance. Finally, the result-
ing software does not seem to be publicly available, although the underlying gaussian modeling
framework is available at https://github.com/carlobaldassi/GaussDCA.jl. Nevertheless, as
a cross check in the supplemental information when predicting binding vs non-binding antibodies,
they use area under curve (AUC) to compare their method (0.97) to aa-cdist (0.86). This indicates
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the surprising usefulness of aa-cdist, especially since aa-cdist is certainly not subject to the same
potential for overtraining.
METHODS
Simulation framework. The simulation of each clonal family in this paper begins with a naive
sequence generated by the partis simulation command [8]. Since in this paper we focus on affinity
maturation rather than VDJ rearrangement, we refer to that paper for all details on its implemen-
tation and validation. This naive sequence is then passed to the bcr-phylo package [15] for GC
reaction simulation. For this paper we have extended the original software by adding a number
of new parameters to allow for more comprehensive variation, as well as optimizing for speed.
The full simulation of a family combining partis and bcr-phylo can be run with the following
script: https://git.io/JvFcW.
The bcr-phylo simulation begins by generating a number of “target” nucleotide sequences from
the naive nucleotide sequence. These targets represent hypothetical optimal antibodies toward
which evolution will be directed, and are chosen at fixed distance from the naive sequence (de-
fault 15 amino acid hamming distance). The representation of the GC reaction proceeds generation
by generation, beginning with the naive sequence’s single cell. In each generation, a number of
offspring is chosen for each cell from a Poisson distribution with parameter λ determined by that
cell’s affinity; if a cell has zero offspring in a generation its lineage ends. The correspondence be-
tween nucleotide sequence and affinity is by default determined by amino acid hamming distance
to target sequence. For a detailed description refer to the supplement of [15], but the gist is that at
each generation a limiting amount of antigen is apportioned among the cells based on their affinity
(inverse dissociation constant) using equations of chemical binding equilibrium, and each cell’s λ
is calculated based on its acquired antigen and the carrying capacity. The net result is a monotonic
increase in mean number of offspring as a cell’s sequence draws closer to a target sequence. We
also tested a model with a much less discrete distribution of possible affinity values, where the
distance for each amino acid pair is rescaled by their BLOSUM similarity (S2 Figure, bottom left).
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In order to introduce a selection strength parameter (bottom right of S2 Figure), instead of deter-
mining the Poisson parameter directly from affinity, we smear it out (rescale it) by drawing from
a normal distribution. The normal distribution’s mean and variance are calculated such that for
a selection strength of 0, affinity has no effect on offspring number, while for selection strength 1
the Poisson parameter is determined directly by affinity (but since the number of offspring is still
drawn from that Poisson, there is still significant stochasticity). Specifically, the parameters for
the ith cell’s normal distribution are given by µi = λ¯ + s(λi − λ¯) and σi = (1 − s)σλ, where s is
the selection strength, λi is the ith cell’s unrescaled (affinity-determined) Poisson parameter, and
λ¯ is the mean and σλ the standard deviation of unrescaled Poisson parameters of all cells. Note
that σi is somewhat arbitrary, but this choice ensures that the variance in rescaled λ over cells is
comparable for all values of s. The simulation is terminated after some number of generations,
referred to as the observation time.
When each child cell is generated, its nucleotide sequence has some probability to suffer a point
mutation. This probability is set based on experimental values, but averages roughly one point
mutation per generation. Synonymous mutations have no effect on affinity, while a nonsynony-
mous mutation that decreases the distance (whether plain or BLOSUM-scaled hamming) to a tar-
get sequence increases affinity, and thus mean number of offspring (Poisson parameter). While
context-dependent mutation is implemented in bcr-phylo (using the S5F model [71]), because this
feature increases run times by too much to allow the generation of the large samples needed for
our validation, all samples shown here have this option turned off. In the limited sample sizes
that we have run with context dependence turned on (results not shown), neither aa-cdist nor
lbi consistently performed either better or worse. The main pattern was that n-shm performed
significantly worse with context dependence turned on.
Given the complete simulated tree of cells, we have to decide which we will sample. In order
to simplify the many ways of choosing N cells from M generations, we focus on two cases that
cover two alternative models for GC cell export: either sampling a fraction of the desired number
of cells every few generations (top row of S2 Figure), or sampling all cells at the end (all others).
In addition, in order to mimic typical phylogenetic programs that infer ancestral sequences, we
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then also recursively sample all MRCA sequences starting with the set of sampled cells (although
we have also run extensive validation without this option, results not shown, and the only signif-
icant effect is due to the change in the fraction of leaf sequences). Different models of GC export
also stipulate different levels of bias toward exporting higher affinity cells. We attempt to cover
the various possibilities with three options (S3 Figure): uniform random (default), sampling with
probability proportional to affinity, and sampling the cells in order of perfectly decreasing affinity.
Unless otherwise noted, in order to isolate the effect of the value of each parameter, every family
in a sample has the same parameter value. However, to demonstrate the effectiveness of choosing
among all families of a given specificity requires that we also vary parameters between families
in a sample. In S5 Figure we show the effects of increasing the variance of parameters between
families by first measuring performance on samples where every family has the same parameter
value (points left of dashed lines), and then on samples where the value for each family is chosen
at random (right of dashed lines in S5 Figure). The idea is to first give some idea of the effect of
changing only the mean value of the parameter (left of the dashed line), and then of changing the
variance (right of the dashed line). For the samples right of the dashed line, the value for each
family is drawn at random from the choices listed in Table 2 (which is summarized on the figure’s
x axis as a range).
Table 2. Parameter variance choices for samples used in points to right of
dashed lines in S5 Figure. “Fig Row” refers to the row in S5 Figure. The indicated
parameter for each family is drawn at random from the listed values, and the
“first”, “second”, and “third” columns refer to the respective x values to the right
of the dashed line in the Figure.
Fig Row parameter first second third
1 N sampled 25, 50, 75 15, 50, 150, 500
2 selection strength 0.5, 0.75, 1.0 0.25, 0.67, 1.0 0.1, 0.25, 0.75, 1.0
3 observation time 50, 100, 200 50, 150, 500, 1000
4 N sampled 50, 150, 300 25, 150, 500
4 selection strength 0.5, 0.75, 1.0 0.25, 0.75, 1.0
4 observation time 100, 250, 500 50, 250, 1000
An unavoidable feature of our approach is that we must simulate a vastly larger number of
sequences than we want to sample. Since every cell in the evolutionary history of the family must
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be simulated, and we want to decide which ancestral cells to sample at the end, large carrying ca-
pacities and observation times dramatically increase the required time and memory. For example,
each point in Fig 1 uses only 4.5 × 104 final sampled sequences, but requires actually simulating
3 × 108 sequences. And the biggest dtr training sample, with 2.5 × 106 final sampled sequences,
required simulating roughly 7× 1010 sequences (Table 4).
When we simulate families with high SHM frequencies, for simplicity we treat them as a single
long-running GC reaction rather than multiple sequential reactions. Real antibodies with 20-30%
SHM are generally assumed to have undergone many cycles of GC completion and reentry over a
number of years (although antibodies with 20% SHM have been observed after only 28 days [72]).
Treating this instead as a single long-running GC reaction, however, is probably a good approx-
imation, because GC completion followed by reentry of memory B cells is similar to a strong se-
lective sweep [73]. This means that GC completion and reentry is largely equivalent to increasing
either the observation time or selection strength.
While it seems likely that most families in most real data correspond to regions of parameter
space far from any optimal antibody or target sequence, it is nonetheless important to explore
behavior as a family reaches the target sequence toward which it has been evolving. For the initial
target distances and carrying capacities used in our simulations, this corresponds to observation
times greater than several thousand generations (i.e. SHM around 20%). In order to maintain some
diversity in these cases, we introduce a minimum target distance threshold (which we set to two
amino acid changes) below which affinity does not increase. Thus when sequences draw nearer to
a target sequence than this threshold, they no longer experience selective pressure to move closer
to the target sequence.
Another limitation of our current approach is that while it can model a single family evolving
toward multiple target sequences, it cannot model competition between families. Doing this ex-
plicitly would be computationally prohibitive, since all the families in a repertoire would need to
interact with each other. However the important features could likely be mimicked by allowing
each family’s carrying capacity to vary with time, simulating the effects of other families’ over-
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or under-utilization of available resources. The biggest problem stemming from this current lim-
itation is that each family operates under a fixed carrying capacity, so we cannot evaluate the
effectiveness of using clonal family size as a method of choosing high-affinity families. As a prac-
tical matter, however, this may not be a significant problem, since the extent to which family size is
an effective predictor depends entirely on how much competition between families really occurs,
which has not yet been definitively established. If different families are in perfect competition
(for instance if we believe that there are either many families within each GC, or lots of transport
between different GCs), then family size is by definition that family’s fitness. On the other hand
if there is little between-families competition, family size would tell us little about fitness, being
determined instead by random chance (e.g. by which family happened to develop in the most
well-resourced GC).
While we have great confidence that our simulation framework effectively recreates the im-
portant features and variation of BCR evolution, we would prefer to also validate on a completely
independent package. Unfortunately, while there are many packages that come close to simulating
what we need [31,74–76], to our knowledge they all lack necessary features. Most frequently, they
do not simulate complete nucleotide sequences, and instead draw a cell’s affinity either directly
from some distribution, or based on a few key residues.
Evaluation framework. While we described the basics of our performance evaluation above, there
are many steps between a simple metric vs affinity scatter plot and the quantiles in Fig 1. The
question we’re trying to answer is, if we take the best few sequences according to our metric,
how high can we expect those sequences to rank in affinity? In a metric vs affinity scatter plot
(left side of Fig 3, or top row of Fig 4) this means taking the highest few points by y, and seeing
where they rank in affinity (x). We calculate these rankings as the quantile in affinity, averaged
over the chosen sequences. For instance the sequences in the top 4% of affinity have quantiles
from 96%-100%, and thus mean quantile 98%. The top 4% of sequences according to some metric,
on the other hand, might have affinity quantiles spread between 85%-100%, which could give a
mean of 92%. This example both neglects ties and assumes infinite sample size; in practice both
are important, which results in jumps and horizontal lines as in Fig 3. This is one reason why it’s
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important to compare to the mean quantile of a hypothetical perfect metric (green dashed lines),
rather than to a constant value of 100. We plot this resulting mean affinity quantile for thresholds
from the 50th to 100th quantile (i.e. choosing from half to none of the sequences, right side of Fig 3,
or middle row of Fig 4).
In order to compare performance over many different parameter choices, we need to summarize
this plot with one number. We do this by defining the deviation from perfect as the difference
between the metric’s performance and that of a hypothetical perfect method (distance between
blue and green lines). We then average this quantity from the 75th to 100th quantiles. This average,
reported as a mean± standard error over many statistically independent samples, is what appears
in Fig 1.
When predicting ∆-affinity, we cannot simply report the mean ∆-affinity quantile of the chosen
sequences because we want to account for being close to, but not exactly on, the correct branch.
We instead imagine moving upward on the tree from the node of interest until reaching a branch
containing an affinity-increasing mutation. We report the number of steps (i.e. ancestors) that
were necessary, so if we’re exactly right this number is 0. Searching only upward reflects the fact
that a mutation can only affect the fitness of nodes below it, and thus a high lbr value at a node
immediately above an important mutation is likely due to random chance rather than a signal of
selection. Nodes with high lbr that are several steps below such a mutation, on the other hand,
simply reflect the fact that increased fitness typically takes several generations to manifest itself
as an increase in observed offspring. In other words searching downward would improve the
apparent performance of a metric, but only by counting as successes cases that were successfully
predicted only through random chance. Another reason we do not also search in the downward
direction is that in a practical sense it is much more useful to know that the important mutation
is above a node than below it. We could imagine in the lab testing one or a few branches above a
node, but because of the bifurcating nature of trees there would be far too many potential branches
below (not to mention adding the ambiguity of potentially going up and then down, i.e. how to
count cousins). One potential issue with this step-counting approach is that it gives equal credit for
being off by long and short branches. We thus also performed extensive validation using the total
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branch length traversed, rather than number of steps (results not shown). The performance was
generally similar, and is also probably less relevant since during inference we don’t control how
long the branches are. For instance any metric would appear to do worse on sparsely-sampled
trees with long branches.
Distance to family consensus sequence (aa-cdist and nuc-cdist). One nice feature of consensus
distance metrics is that, unlike lbi and lbr, there is no inference inaccuracy: they are a direct result
from observed sequences. However, these observed sequences will in some cases not accurately
represent the entire family. In order to quantify this inaccuracy, we calculated the full-family
consensus sequence, and then compared it to consensus sequences calculated with smaller subsets
of the family (S7 Figure). While the nucleotide consensus can be quite inaccurate (top), we only
calculate it in order to inform comparison between aa-cdist and lbi. The amino acid consensus,
on the other hand, is quite accurate, reaching an error of one position (out of around 130) only for
sampled families smaller than 10 sequences and very early times (i.e. when almost no selection
has yet occurred, S7 Figure bottom left).
local branching index (lbi). The authors of [5] introduce lbi as an approximate metric to supple-
ment their more complex likelihood-based measure. However, they find that the two perform
very similarly, so the full likelihood calculation is probably more useful for building intuition (and
motivating lbi) than for practical use. The lbi score for each node in the tree is computed as the
total of all nearby branch lengths, weighted by an exponential function of the distance away from
that location with scale τ (S1 Figure).
τ optimization. The decay length τ determines the size of the local area that impacts each node’s
lbi. The authors of [5] suggest using 0.0625 times the average pairwise distance between sequences
(elsewhere they use the TC/
√
logN and TC/15, for TC the coalescence time, but since we’re not
using coalescent models this is less useful here). While these estimates are based on a thorough
optimization, they result in a τ that depends on which sequences are sampled, which precludes
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comparisons between families, as well as between samples in different papers. Since these com-
parisons are important for us, we perform an optimization from a somewhat different perspective,
although we end up with a comparable value.
We begin by noting that the sequence length has a profound effect on the distances over which
trees branch, and for BCR sequences it is constant across families and samples. The minimum
possible branch length, corresponding to one point mutation, is equal to the inverse sequence
length 1/`seq. Thus from first principles/dimensional analysis we expected this to be a reasonable
guess for τ . However, we also want a value that gives optimal performance, so we measured
performance vs τ in a number of parameter scans similar to Fig 1. The strongest dependence was
vs number of sampled sequences as a fraction of carrying capacity (S9 Figure, top row). While
the most important message from this plot is probably that lbi performance does not depend very
strongly on τ , there is a pronounced peak in performance at 1/`seq ' 1/400 = 0.0025, especially
when choosing within families (top right), where lbi is most important. We get a similar value if
we (roughly) calculate the recommendation from [5] for 10% SHM: 0.0625× 0.10 = 0.00625. Thus
we recommend using τ = 1/`seq for general use, which for BCR sequences is about 0.0025.
As mentioned above, because sequence multiplicity is experimentally difficult to accurately
measure, we do not generally recommend its use, since any spurious multiplicities could easily
overwhelm the information from unique sequences, which is likely to be more accurate. However,
in cases where they are reliable, multiplicities would be an extremely useful source of additional
information. If a cell has three sampled offspring, for instance, that is a strong indication of fit-
ness regardless of whether the offspring all have identical BCR sequences. Our implementation
of lbi thus incorporates any multiplicity information that has been passed in for each node (see
https://git.io/JJCGe). It works by adding additional dummy branches above any node that
has multiplicity greater than 1. For instance a node with multiplicity 3 will have 3 branches con-
necting it to its parent, rather than 1. This represents the case where the three observed sequences
all “split off” at the top of the branch to its parent. In reality a split point somewhere in the middle
of the branch would likely be more accurate, but we think that the current approach is a reasonable
first approximation.
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lbi normalization. In general, both the absolute magnitude of lbi and its value relative to other se-
quences are meaningful. For influenza virus evolution, however, which was the case of most inter-
est to [5], only the relative value is useful, since there is only one global influenza “clonal family”,
and we know that at least some of these viruses will survive in the future (i.e. we definitely want
to “choose” some of them). They thus normalize lbi to the maximum value within the tree [70],
discarding all information on its magnitude. Our case, however, is quite different: we are trying
to determine how good an antibody is likely to be, so we care very much about the magnitude.
Magnitude tells us whether this is a really branchy bit of the tree, not just whether it’s branchier
than the rest of the tree.
We go further than using the magnitude of lbi, however, and normalize this value relative to
two universal and intuitively meaningful minimum and maximum values. One reason is that raw
lbi can only be compared to other values that were calculated with the same τ : a comparison to
calculations that used a different τ , or simply don’t report τ , is meaningless.
We thus look for some theoretically meaningful minimum and maximum values of lbi, and set
them to 0 and 1. Note that these don’t have to be the actual smallest and largest possible values
in order to be useful: for instance the Centigrade temperature scale definitions of 0 and 100 are
entirely analogous.
To find a maximum value, we construct a synthetic tree representing the “very branchy” case,
then search among its nodes for the maximum value. We generate such a tree by bifurcating af-
ter every point mutation (i.e. after a branch length of 1/`seq), then find the node in the tree with
maximum lbi. In order to avoid dependence on the depth of this tree, we start with small N gen-
erations, and increase depth until (hopefully) reaching an asymptote. If it diverges, i.e. does not
reach an asymptote, the exercise is not meaningful (indeed when we N-furcate for N > 2 it never
converges, results not shown). Calculating this numerically, we find that the maximum value con-
verges to an asymptote for τ less than around 1/`seq, but diverges for larger values (S10 Figure).
Luckily τ optimization resulted in a comparable recommendation. While this bifurcating tree is
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of course only one of many possible choices, its purpose is to serve as some reasonable bench-
mark: when looking at a node with lbi of 1, it’s very useful to know that its local area is roughly as
branchy as a tree that bifurcates every 1/`seq.
Finding a minimum value is easier: we construct the (deep) caterpillar tree and find the min-
imum lbi among its nodes. This minimum is simply τ , a result which can also be obtained by
performing a trivial analytic integration. We thus normalize lbi such that this minimum value is
0, and the maximum value (previous paragraph) is 1. Note that leaves in shallow trees can thus
have values less than 0, and dense trees can result in values greater than 1.
Dummy branches. An inherent bias in the lbi calculation is that nodes near the edge of the tree (i.e.
near root or leaves) are systematically biased low. While there is no way to address the underlying
reason for this – by definition we don’t know what happens before root or after leaves – we can
test some corrections. Calculating lbi on a (normal) tree that ends abruptly at leaves and root
amounts to using the implausible prior that root sprang forth from nothing, and that every leaf
died immediately upon sampling (or rather, would have died even without being sampled). We
can instead use the much more plausible prior that the status quo at these times continued to
±infinite time by adding long “dummy” branches above root and below each leaf. Unfortunately
this does not turn out to improve performance (results not shown). We suspect that this is because
we actually know another key piece of information that is not encoded in lbi: most novel mutations
are deleterious. In other words the fact that lbi is biased low for leaves is compensated for by the
fact that for external reasons we know that leaves are typically low fitness.
Relative fitness. We also note that, by design, lbi measures a cell’s fitness relative to cells alive at the
same time (i.e. cells against which it was actually competing). Thus in any situations that involve
sampling sequences from many different time points (e.g. sampling lots of ancestral sequences)
performance suffers in an absolute sense. This can be ameliorated in practice simply by paying
attention to the location of nodes within a tree, and keeping in mind that affinity likely increases
for much of the length of the tree.
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AA local branching index (aa-lbi). The basic goal of this metric is to recreate the local branching
calculation on a tree that reflects only nonsynonymous changes, thus ignoring the significant noise
introduced in nucleotide lbi by synonymous mutations. To make this “amino acid tree”, we begin
with the nucleotide tree, and set the length of each edge to the fractional amino acid hamming
distance between the sequences of its two nodes. Unlike nucleotide lbi, this procedure requires an
inferred ancestral sequence for each internal node, so it cannot be run on trees produced by faster
methods such as FastTree that are suitable for use on full repertoires, and instead requires methods
such as RAxML (see “Tree inference methods” below). Another possibility would be to infer the
tree directly on the amino acid sequences; while this would result in a less accurate topology, it
might be accurate enough for the aa-lbi calculation.
local branching ratio (lbr). We calculate lbr with the same integrals as lbi, so much of that dis-
cussion applies here as well. The difference is that instead of adding up the branch lengths in
all directions, we instead divide those below the node by those above and beside it (S1 Figure).
This results in a very sharp distinction between the effects of mutations above the parent vs those
below.
As for lbi, we performed an optimization of the decay length τ , but with quite different results
(S9 Figure). First, the variation in performance is much more significant. Second, there is no peak
in performance: instead it improves monotonically as τ increases to very large values. This makes
sense since larger τ means that more of the tree is visible, which adds information. For lbi, however,
there is a countervailing effect: resolution as to which node we’re focusing on is also determined by
τ , which disfavors large τ . But the resolution of lbr is determined by the sharp distinction between
numerator and denominator, so τ can increase without penalty. Another way of explaining why
lbr improves with larger τ is that if a fitness-increasing mutation has just occurred, the chances
of having many offspring in the first generation is likely not very close to 1 even if it is strongly
advantageous (for example, let’s say it’s 1/3). But as we proceed down the tree, the chance of
any of the next few generations having many offspring is much closer to one, for instance after
five generations it would be 1 − (1/3)5 = 0.99. We thus (somewhat arbitrarily) choose to use τ of
20×1/`seq for lbr.
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While the same normalization procedure could be followed as for lbi, there is no point, because
lbr is an inherently unitless ratio.
In the case of lbi above, we concluded that adding “dummy” branches to correct for biases did
not make sense. For lbr, however, we have an additional consideration: lbr begins to diverge for
nodes near the root, since there is no branch length above the root (in the denominator). Because
this is highly undesirable, we add a very long dummy branch above the root node during lbr
calculation.
Tree inference methods. When evaluating the simulation performance of metrics that depend on
trees (lbi, lbr, aa-lbi, aa-lbr, and ∆-lbi), we use only the true simulated tree. This is because we
want to separate the ability of the metrics to predict affinity or ∆-affinity from the performance
of a particular phylogenetic inference method. We then separately evaluate the robustness of the
lbi and lbr calculations to use of the fast but relatively inaccurate tree inference that partis uses by
default (S8 Figure). We find in this test that tree inference matters very little for lbi, but is impor-
tant for lbr. This makes sense, since lbi depends on shorter range comparisons between similar
sequences that are likely easier to capture with a heuristic tree method, while lbr is sensitive to the
longer range details of ancestral inference. It would be useful to also make this comparison for
other phylogenetic inference programs and over the huge variety of tree characteristics encoded
by our simulation parameters. As these programs get more accurate, however, they also get much
slower, so this will require a substantial time investment.
The cases we can envision where better phylogenetic inference is important will usually in-
volve only a few families, and trees can thus be inferred separately using programs such as
linearham [39] or RAxML [40]. These trees would then be passed to partis for selection met-
ric calculation using the --treefname option of the get-selection-metrics action (see https:
//git.io/JfeGk). Most commonly this would be necessary after an antibody of interest has al-
ready been chosen. In such a case we would want to infer ancestral sequences in that antibody’s
family (which partis cannot currently do), and then include these ancestors in the selection metric
calculation. Such a workflow was followed in [41] (albeit without the selection metric calculation).
This used the linearham package for accurate Bayesian inference of both trees and naive sequences
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(see https://github.com/matsengrp/linearham), and the Olmsted package for visualization
(see https://github.com/matsengrp/olmsted), which are both highly recommended.
The fast but heuristic tree inference method that is currently included in partis combines the
history of its clustering algorithm with the FastTree inference program. Because this clustering
proceeds via hierarchical agglomeration [1], the history of the clustering process itself constitutes
a tree. While this tree is based only on sequence similarity measures (either inferred naive ham-
ming distance or the partis VDJ rearrangement likelihood) rather than a model of sequence evolu-
tion, in many cases the result will be quite similar. The biggest inaccuracy in using this approach
for tree inference is that the agglomeration frequently merges many clusters together in a single
step, resulting in a large multifurcation in the tree. Typically the largest of these happens in the
initial clustering step, when it merges together input sequences with very similar inferred naive
sequences (for details and thresholds see [1]). We thus refine the clustering-based tree by remov-
ing any subtree whose root has more than two offspring, and replace it with a subtree inferred by
FastTree [77]. Because FastTree forces any observed ancestral sequences to be very short leaves
hanging off of the corresponding internal node, we then also collapse any such leaf with length
less than 0.5×1/`seq. Note that this method does not allow for ancestral sequence inference, which
for detailed studies of single families will be quite important.
The speed of this calculation is entirely dependent on how much of the tree needs to be inferred
via FastTree, since the non-FastTree parts come along for free from the already-completed clus-
tering. But on typical BCR NGS samples, the only appreciable time is taken for the largest few
families, and a family of for instance several thousand sequences can be expected to take a few
minutes.
Decision tree regression (dtr). The fact that we have several very different metrics that perform
adequately suggests that we combine them using some form of machine learning. We focused on
decision tree regressors, and found that gradient boosting generally performed better than other
methods. We tried many combinations of input variables, but found no benefit to reducing their
number from the full set, which is shown in Table 3. We trained different dtr versions both for
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choosing among all families and for choosing within each family, as well as for predicting both
affinity and ∆-affinity.
Because we need the dtr to perform well for all possible combinations of parameters, we must
construct a training sample consisting of families exhibiting a huge variety of characteristics,
which requires an extremely large number of families. The types of samples used for the parame-
ter scans, such as Fig 1, are useless for this, since they hold all but one or two parameters constant.
We thus made several highly variable samples (Table 4), each generated by first choosing a distri-
bution for each parameter. To simulate a family, a value for each parameter is then drawn from
that parameter’s distribution. We generated between two and five independent samples for each
set of parameter distributions, i.e. the dtr was trained on one sample of the indicated size, while
there was at least one other sample for testing that had identical underlying parameters, but was
generated with a different random seed. We also tested on all other combinations of parameter
distributions, as well as the slice/scan samples from e.g. Fig 1. Finally, we also tested a compre-
hensive variety of the parameters describing dtr training (e.g. number of estimators, decision tree
depth, and pruning details). Note that we test on training samples only in order to evaluate sta-
tistical overtraining, i.e. to ensure that performance is comparable on samples that differ from
the training sample only by random seed; we never report or talk about the “performance” on a
training sample.
Here we summarize our conclusions; full results can be found at https://zenodo.org/record/
3929565. We managed to create a dtr that in most regions of parameter space roughly recapitulates
the performance of the best single metric (usually aa-cdist or aa-lbi), but improves upon it only
slightly (perhaps a few percent). Because of the significant complication introduced by the use of
any machine learning method, and their lack of interpretability, we think they are only worthwhile
in cases where they improve performance by much more than this. This is of course influenced
by the fact that we have one metric (aa-cdist) performing well everywhere; if different regions of
parameter space required different single metrics, the dtr would be much more attractive.
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It is difficult, if not impossible, to definitively attribute the dtr’s failure to improve performance
as much as we expected, since we cannot directly measure whether these expectations were rea-
sonable. However, we think it is highly likely that there is significant additional information in
the more poorly-performing variables, and we are also quite confident that a number of features
of our use case make it particularly challenging for a machine learning approach. The metrics lbi
and aa-cdist are far from perfectly correlated (Fig 4, at bottom), and while this discordance is of
course not entirely due to useful independent information, lbi clearly contains tree and locality in-
formation that is not included in aa-cdist. One challenging feature of our case is that the inferred
tree quantities that serve as input variables (e.g. n-shm, Fay/Wu H) are very noisy predictors of
the true tree parameters are (e.g. observation time, selection strength, carrying capacity). To take
one example, the relative performance of lbi and n-shm completely reverses between low and high
selection strength (blue and orange in bottom right of S2 Figure), but Fay/Wu H is far too poor
an estimator of selection strength to give the dtr an accurate idea where along the x axis it is for
a given family (results not shown). It is likely that more sophisticated tree inference would im-
prove performance by allowing the use of more fundamental tree variables as input. It is also of
course entirely possible that a different machine learning approach would be able to improve on
our efforts; however given the exemplary performance of aa-cdist alone, we do not feel that this
is a high priority.
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Table 3. Decision tree regression (dtr) input variables. The among-families dtr
uses both per-sequence (top) and per-family (bottom) metrics; while the within-
family dtr uses only the former. aa-lbi and aa-lbr were not included only because
they were developed after completion of the dtr study.
per-sequence metrics description
aa-cdist see Table 1
nuc-cdist see Table 1
lbi see Table 1
lbr see Table 1
n-shm see Table 1
n-shm-aa amino acid distance to family naive sequence
edge dist. min. distance in tree to either root or tip
per-family metrics description
Fay/Wu H measures selection via excess in site frequency spectrum [68]
nuc cons seq SHM nucleotide distance from family consensus sequence to naive sequence
aa cons seq SHM amino acid distance from family consensus sequence to naive sequence
mean n-shm mean number of nucleotide mutations among sequences in the family
max lbi maximum lbi value in the family
max lbr maximum lbr value in the family
Table 4. Parameters used for dtr training samples. Versions v0-v2 sampled parameters
for each family from uniform distributions of the indicated mean and half-width, while v3
sampled with equal probability from the indicated discrete values.
N families selection
label per sample N samples carry cap. obs times N sampled strength
v0 1000 5 1500 ± 1000 150 ± 75 150 ± 100 0.75 ± 0.25
v1 50000 5 1500 ± 1000 150 ± 75 30 ± 7.5 0.75 ± 0.25
v2 300000 2 1500 ± 1000 150 ± 75 20 ± 7.5 0.75 ± 0.25
v3 50000 2 250,500,900,1000,1100,1500,5000 75,100,150,200,1000 15,30,75,150,500 0.5,0.9,0.95,1.0
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SUPPLEMENTARY INFORMATION
S1 Figure. Cartoon showing calculation of lbi (left) and lbr (right). The dark-
ness of each branch represents the exponentially decaying weight factor, which
decreases with distance from the node (in red) for which we’re calculating the
metric. On the left, we show a node with low lbi (top) and high lbi (bottom). At
right, in calculating lbr for the red node, we split the tree into two pieces: offspring
of the node in the numerator; and parents, siblings, cousins, and their offspring in
the denominator.
44
S2 Figure. Simulation performance for affinity prediction within families,
similar to Fig 1 but for scans across a variety of different parameters. Perfor-
mance is shown vs observation times (units of N generations), where sampling
occurred at five different time points spanning the indicated values for carrying
capacity of both 350 (top left) and 2000 (top right). This is in contrast to Fig 1,
where sequences were sampled only at the same, final time point. Performance
is also shown vs carrying capacity with 30 (middle left) and 150 (middle right)
sampled sequences per family; vs observation time for a non-default affinity cal-
culation utilizing BLOSUM matrices (bottom left); and vs a parameter describ-
ing the strength of selection (bottom right). The corresponding among-family
plots, as well as plots for many other parameter combinations, are in https:
//zenodo.org/record/3929565.
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S3 Figure. Simulation performance for within-family affinity prediction with
different sampling schemes vs N sampled sequences per family for aa-cdist
(left) and lbi (right). Schemes shown are “uniform random” (the default, which is
shown in all other plots), “affinity biased” (the probability of sampling each cell is
proportional to its affinity), and “perfect affinity” (sample the N cells with highest
affinity). Corresponding among-families plots, and plots for all other metrics, are
at https://zenodo.org/record/3929565.
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S4 Figure. Simulation performance for within-family affinity prediction with
different numbers of “target sequences” vs observation time for aa-cdist (left)
and lbi (right). The target sequence represents a hypothetical optimal antibody
toward which selection is directing the cells (see text). Shown for 1, 2, and 4
independently-chosen target sequences (top); as well as for 4, 8, and 16 target
sequences divided among the indicated number of “clusters” of target sequences
(bottom). Corresponding among-families plots, and plots for all other metrics, are
at https://zenodo.org/record/3929565.
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S5 Figure. Simulation performance for affinity prediction when parameters
vary between the families in a sample, shown both for choosing within each fam-
ily (left) and among all families (right). Within each plot, families in samples used
to calculate points with x values to the left of the dashed line all have the same
parameters, whereas those to the right have values sampled from the indicated
range. For instance when varying N sampled sequences (top row), 15 sequences
were sampled from every family in the leftmost points; whereas in making the
rightmost points the number of sequences sampled from each family varied be-
tween 15 and 500. In the top three rows, we vary only one parameter at a time
between families (N sampled, observation time, and selection strength), while in
the bottom row we vary all three at once.
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S6 Figure. Performance on real data for lbi from [32] (top) and [33] (bottom).
See caption to Fig 3
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S7 Figure. Accuracy of the consensus calculation as a function of number of
sampled sequences for nucleotide (top) and amino acid (bottom) consensus se-
quences. This shows the two extremes of parameters that seem to affect accuracy
the most: very early times and small carrying capacities (left) vs very late times
and large carrying capacities (right). Each point is the mean (± standard error)
of 50 families, each with '150 sequences. The y value is the hamming distance
(i.e. inaccuracy) between the consensus sequence calculated with the indicated
number of sampled sequences (x axis) and the consensus sequence calculated on
the entire family.
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S8 Figure. Comparison of lbi (left) and lbr (right) calculated on true trees (x
axis) vs inferred trees (y axis), as scatter plots with Pearson’s linear correlation
coefficient. Inferred trees are made with the approximate, but very fast, method
run by default partis (see Methods). The lefthand plot suggests that lbi is largely
insensitive even to very heuristic tree inference. In the righthand plot, on the
other hand, the handful of points with highly discrepant true and inferred values
indicate that for lbr it is worth using a more sophisticated phylogenetic inference
program if at all possible.
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S9 Figure. Effect of exponential decay length τ variation on performance when
sampling different fractions of the carrying capacity (colors) for lbi (top) and lbr
(bottom) when choosing among all families (left) and within each family (right).
Dashed red line corresponds to the value expected from dimensional analysis
1/`seq = 1/400. The fraction observed corresponds to sampling between 30 and
200 sequences from a carrying capacity of 1000. Note that the vertical ordering of
lines (i.e. whether performance is better for higher or lower sampling fractions)
is not really informative in this plot – the order reverses depending on whether
we sample ancestors or not, i.e. to a large extent it just measures the fraction of
sampled sequences that are leaves.
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S10 Figure. Finding a maximum lbi value to use for normalization at differ-
ent τ values (colors) with both linear (left) and log (right) scales. Plots show the
maximum lbi value among the nodes in a particular reference synthetic “super
branchy” tree as a function of tree depth (N generations). The asymptotic value
for 1/`seq = 1/400 is shown in dashed red; the maximum lbi value converges to an
asymptote for τ less than this, while for τ greater than this the maximum diverges.
